[Pulmonary involvement in patients with hypertensive disease]

Area of Science:

• Pulmonary Medicine
• Cardiovascular Research
• Internal Medicine

Background:

• Hypertensive disease (HD) is a prevalent condition with known cardiovascular effects.
• The potential impact of HD on pulmonary function is not fully understood.
• Previous research has not extensively explored the lungs as a target organ in hypertension.

Purpose of the Study:

• To investigate the relationship between hypertensive disease severity and pulmonary function parameters.
• To determine if arterial pressure monitoring correlates with lung function tests.
• To assess the association between hypertensive complications and lung capacity.

Main Methods:

• Spirometry, body plethysmography, and pulmonary diffusion capacity were measured in 46 patients with stage I-II hypertensive disease.
• Patients were free of other respiratory or cardiovascular conditions, obesity, and smoking history.
• 24-hour arterial pressure monitoring was utilized.

Main Results:

• Increased hypertensive disease severity correlated with impaired pulmonary ventilation capacity.
• Negative correlations were observed between 24-hour arterial pressure and spirometry parameters.
• Microalbuminuria and endothelial dysfunction progression were linked to reduced pulmonary vital capacity, alveolar volume, and diffusion capacity.

Conclusions:

• The findings suggest that the lungs can be a target organ in hypertensive disease.
• Hypertension may lead to measurable declines in lung function.
• Further research is warranted to elucidate the mechanisms linking hypertension and pulmonary impairment.